BeOne Medicines And 2 Stocks That May Be Undervalued By The Market
Name
Current Price
Fair Value (Est)
Discount (Est)
Verra Mobility (VRRM)
$24.37
$47.84
49.1%
Valley National Bancorp (VLY)
$8.90
$17.36
48.7%
TXO Partners (TXO)
$15.08
$29.95
49.7%
Mid Penn Bancorp (MPB)
$26.53
$52.26
49.2%
Lyft (LYFT)
$15.53
$30.54
49.1%
Horizon Bancorp (HBNC)
$14.83
$29.11
49.1%
Expand Energy (EXE)
$117.35
$233.70
49.8%
Central Pacific Financial (CPF)
$26.72
$51.99
48.6%
Brookline Bancorp (BRKL)
$10.43
$20.74
49.7%
Berkshire Hills Bancorp (BHLB)
$25.04
$49.25
49.2%
Click here to see the full list of 163 stocks from our Undervalued US Stocks Based On Cash Flows screener.
We'll examine a selection from our screener results.
Overview: BeOne Medicines Ltd. is an oncology company focused on discovering and developing cancer treatments globally, with a market cap of $32.59 billion.
Operations: The company's revenue is primarily generated from its pharmaceutical products, amounting to $4.18 billion.
Estimated Discount To Fair Value: 47.2%
BeOne Medicines is trading at 47.2% below its estimated fair value, indicating a potential undervaluation based on cash flows. The company has a robust pipeline, including investigational medicines for breast cancer and the approved drug BRUKINSA®, which contributes to its hematology franchise. Recent strategic moves, such as redomiciliation to Switzerland and expanding manufacturing capabilities with an $800 million facility in New Jersey, bolster BeOne's growth strategy and operational resilience.
Our expertly prepared growth report on BeOne Medicines implies its future financial outlook may be stronger than recent results.
Take a closer look at BeOne Medicines' balance sheet health here in our report.
Overview: Elastic N.V. is a search AI company providing hosted and managed solutions for hybrid, public, private, and multi-cloud environments globally, with a market cap of $9.12 billion.
Operations: Elastic generates its revenue primarily from its Software & Programming segment, which amounted to $1.48 billion.
Estimated Discount To Fair Value: 33.9%
Elastic is trading at 33.9% below its estimated fair value, highlighting potential undervaluation based on cash flows. The company anticipates revenue growth of 11.5% annually, outpacing the broader US market. Despite recent insider selling and a current net loss of US$108.11 million for the year, Elastic's strategic collaboration with AWS aims to enhance AI capabilities and drive innovation, potentially supporting future profitability and operational scalability.
Our earnings growth report unveils the potential for significant increases in Elastic's future results.
Click here and access our complete balance sheet health report to understand the dynamics of Elastic.
Overview: Truist Financial Corporation is a financial services company offering banking and trust services in the Southeastern and Mid-Atlantic United States, with a market cap of approximately $53.25 billion.
Operations: Truist Financial's revenue is primarily derived from its Consumer and Small Business Banking segment at $11.04 billion and Wholesale Banking segment at $10.12 billion, while the Treasury & Corporate segment reported a negative contribution of -$9.62 billion.
Estimated Discount To Fair Value: 36.4%
Truist Financial is trading over 20% below its estimated fair value, suggesting potential undervaluation based on cash flows. Despite a dividend yield of 5.12% that may not be fully covered by earnings, the company anticipates revenue growth of 15.2% annually, surpassing the US market average. Recent strategic moves include a $1.25 billion fixed-income offering and innovative payment solutions enhancing cash flow management and operational efficiency for clients, strengthening its financial position amidst board changes and technological advancements.
According our earnings growth report, there's an indication that Truist Financial might be ready to expand.
Delve into the full analysis health report here for a deeper understanding of Truist Financial.
Unlock more gems! Our Undervalued US Stocks Based On Cash Flows screener has unearthed 160 more companies for you to explore.Click here to unveil our expertly curated list of 163 Undervalued US Stocks Based On Cash Flows.
Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ONC ESTC and TFC.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Mauna Kea Technologies Reports First Half 2025 Revenue
PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced its revenue for the first half and the first two quarters of 2025, ended June 30, 2025. First Half of 2025 Performance Summary Total revenue for the first half of 2025 amounted to €3.7m, representing a slight decline of 5% compared to H1 2024. U.S. revenue for the first half of 2025 grew by +14% as reported and +17% in constant currency, with a significant dollar depreciation against the euro, especially in Q2 2025. U.S. operations remained robust, with accelerated growth in Q2 2025: sales rose +23% at constant currency vs. Q2 2024, and up +11% in Q1 2025 vs. Q1 2024, boosted by the expansion of the sales team. Growth in the U.S. was primarily driven by system and probe sales, particularly in the pancreatic cysts indication, more than offsetting a decline in PPU revenue due to the gradual impact of lower Medicare reimbursement rates starting in 2024. In Europe, business activity was gradually impacted by the Company's financial context. However, this decline was almost entirely offset by strong performances in other regions. Sacha Loiseau, Ph.D., Chairman and CEO of Mauna Kea Technologies, stated: 'This first half confirms the relevance of our strategic decisions in our primary market, the United States, where we are seeing continued and sustained sales growth. This momentum is all the more noteworthy given that it was achieved with a reduced sales force, reflecting a strong increase in sales productivity per representative, now at a record level of over $900K, compared to just $200K in 2021. W e are also observing increased usage of Cellvizio and growing interest from new centers, particularly for indications such as pancreatic cysts and food intolerances. Pay-per-use procedure volumes have remained stable at over 800 per quarter for the past year, despite the reduction in Medicare reimbursement. The signing of three new hospitals at the end of H1 gives us confidence in a rebound in volumes going forward. I n Europe and the rest of the world, where our approach remains more opportunistic due to the lack of reimbursement, our activity was impacted by the financial environment. We are currently restructuring the organization to quickly improve efficiency in the coming months, including geographic expansion into high-potential markets such as Australia, which we recently announced. T he financial situation currently faced by Mauna Kea has, of course, had an impact on the Company's operations. However, the slight decline in revenue for the first half reflects the resilience of our business model. During this period of focus on restructuring efforts, we view the revenue level achieved in H1 as a solid performance.' Update on Safeguard Procedure On July 10, 2025, Mauna Kea Technologies received court approval to initiate a "classes of affected parties" procedure, a framework introduced by the 2021 reform of France's business insolvency law. This process groups creditors into different classes to vote on a comprehensive restructuring plan. In this framework, Mauna Kea Technologies will present a plan in the coming weeks, aimed at significantly reducing its debt, to be submitted to the vote by the various creditor classes. As a reminder, the Company's current cash runway extends through November 2025. Discussions are underway, as part of this safeguard procedure, with strategic investors and family offices to secure long-term financing to support its sustainable development plan toward profitability. Key Highlights for the First Half 2025 U.S. Commercial Productivity U.S. Commercial Productivity 2021 2022 2023 2024 Q1 2025 Q2 2025 Revenue per sales rep (in $K) 1 281 551 629 626 832 913 Avg. number of sales reps (over the period) 17 8 8 6 4 6 Expand As of January 1 st, 2025, the U.S. sales team had 4 representatives, down from 8 at the beginning of 2024. Despite this reduction, the revenue increased significantly over the half year period. Since mid-2024, new initiatives have been implemented, both in terms of sales tactics in response to Medicare reimbursement cuts and sales organization effectiveness, with the promotion of two representatives to national leadership roles. These actions have led to a significant increase in per-rep productivity, reaching historic levels of around $800K to $900K in annual sales per representative. This positive momentum also supported the hiring of two new sales representatives during the first half of 2025, who quickly became operational. Pay-Per-Use (PPU) Procedure Volumes PPU procedure volume, which had gradually slowed in 2024 due to Medicare reimbursement cuts, has stabilized at over 800 procedures per quarter. At the end of Q2 2025, three new PPU accounts were signed, marking the first new contracts since Q3 2024. This recovery signals renewed commercial momentum and indicates potential for volume rebound. Furthermore, the Company is actively working toward a reimbursement reclassification, notably by correcting hospital-submitted reporting data and collaborating closely with physician associations and Medicare authorities. Revenue by Geography – H1 2025 By geography, business was mainly driven by the U.S., where the Company recorded a +14% growth as reported and +17% at constant currency (CC), with a dollar depreciation against the euro, especially in Q2 2025. This growth was primarily driven by system and probe sales, particularly in the pancreatic cysts indication, offsetting a decline in PPU revenue due to the gradual impact of lower Medicare reimbursement rates starting in 2024. In Europe, business activity was gradually impacted by the Company's financial context. However, this decline was almost entirely offset by strong performances in other regions. Revenue by Category – H1 2025 'We remain fully committed to ensuring that the safeguard procedure results in a situation that allows Mauna Kea Technologies to achieve financial stability. At the same time, we are actively structuring the financial resources necessary to execute our development plan, with the aim of transforming Mauna Kea into a Company that delivers both growth and profitability", concluded Sacha Loiseau. A ppendix - Details of Revenue for Q1 and Q2 2025 About Mauna Kea Technologies Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio® platform is used globally across a wide range of medical specialties and is making a transformative change in the way physicians diagnose and treat patients. For more information, visit Disclaimer This press release contains forward-looking statements about Mauna Kea Technologies and its business. All statements other than statements of historical fact included in this press release, including, but not limited to, statements regarding Mauna Kea Technologies' financial condition, business, strategies, plans and objectives for future operations are forward-looking statements. Mauna Kea Technologies believes that these forward-looking statements are based on reasonable assumptions. However, no assurance can be given that the expectations expressed in these forward-looking statements will be achieved. These forward-looking statements are subject to numerous risks and uncertainties, including those described in Chapter 2 of Mauna Kea Technologies' 2024 Annual Report filed with the Autorité des marchés financiers (AMF) on April 30, 2025, which is available on the Company's website ( as well as the risks associated with changes in economic conditions, financial markets and the markets in which Mauna Kea Technologies operates. The forward-looking statements contained in this press release are also subject to risks that are unknown to Mauna Kea Technologies or that Mauna Kea Technologies does not currently consider material. The occurrence of some or all of these risks could cause the actual results, financial condition, performance or achievements of Mauna Kea Technologies to differ materially from those expressed in the forward-looking statements. This press release and the information contained herein do not constitute an offer to sell or subscribe for, or the solicitation of an order to buy or subscribe for, shares of Mauna Kea Technologies in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The distribution of this press release may be restricted in certain jurisdictions by local law. Persons into whose possession this document comes are required to comply with all local regulations applicable to this document. 1 Annualized sales for the first and second quarters of 2025
Business Wire
2 hours ago
- Business Wire
Rising Threats Trigger U.S. Public Sector Security Upgrades
STAMFORD, Conn.--(BUSINESS WIRE)--Public-sector organizations in the U.S. are adopting advanced cybersecurity solutions and services in response to a growing number of data breaches and evolving threats, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm. Public agencies need strong data protection strategies to continue delivering services and maintain public trust. They are working with providers to acquire and deploy effective security technologies and services. Share The 2025 ISG Provider Lens® Cybersecurity — Services and Solutions report for the U.S. Public Sector finds that agencies at the federal, state and local levels face increasingly sophisticated attackers targeting critical infrastructure and citizen data. The constant battle to protect data and infrastructure further complicates the government's digital transformation efforts, including integration of AI-enabled systems. 'Public agencies need strong data protection strategies to continue delivering services and maintain public trust,' said Nathan Frey, ISG partner and lead, U.S. Public Sector. 'They are working with providers to acquire and deploy effective security technologies and services.' Organizations are starting to employ AI to enhance security even as threat actors are weaponizing it, the report says. AI can automate the discovery of vulnerabilities and create more evasive malware and convincing deepfakes for social engineering. At the same time, agencies are using AI tools to enhance threat detection and conduct predictive analysis. They are also taking steps to protect AI models and data from attacks, guided by government standards such as the NIST AI Risk Management Framework. Risks to the public sector also arise from supply chain issues and the convergence of IT and OT systems, ISG says. The complex supply chains involved in government procurement come with vulnerabilities that require constant vendor risk management and monitoring. IT/OT convergence in critical energy, water, transportation and defense infrastructure can be compromised to disrupt operations, putting the public at risk. An early notification system prevented a major ransomware attack against transportation infrastructure in the U.S. in 2023. As agencies migrate to the cloud, they are deploying cloud security posture management and workload protection platforms to protect sensitive applications across distributed systems, the report says. Facing internal resource constraints, many are adopting managed detection and response services, which include continuous monitoring, threat hunting, expert-led incident response and other capabilities. Service providers play crucial roles in the U.S. public sector's cybersecurity and resilience, ISG says. At a strategic level, they relate cyber risks to agency objectives, demonstrating return on investment. Providers also help agencies meet strict compliance requirements and augment internal teams in a sector that often struggles to attract and retain cybersecurity talent. 'Cybersecurity services are stepping up to meet increasing public-sector demands for resilience and governance,' said Gowtham Sampath, assistant director and principal analyst, ISG Provider Lens Research, and lead author of the report. 'Providers enable clients to align security measures with agency goals and build effective defenses with limited resources.' The report also explores global cybersecurity technology trends relevant to the U.S. public sector, including increasing adoption of Identity and Access Management (IAM), extended detection and response (XDR) and security service edge (SSE). For more insights into the cybersecurity challenges facing U.S. public agencies, along with ISG's advice for addressing them, see the ISG Provider Lens® Focal Points briefing here. The 2025 ISG Provider Lens® Cybersecurity — Services and Solutions report for the U.S. Public Sector evaluates the capabilities of 86 providers across six quadrants: Identity and Access Management (Global), Extended Detection and Response (Global), Security Service Edge (Global), Technical Security Services, Strategic Security Services and Next-Gen SOC/MDR Services. The report names IBM as a Leader in five quadrants. It names Accenture, Capgemini, Deloitte, EY, HCLTech and Infosys as Leaders in three quadrants each. Broadcom, Fortinet, KPMG, Microsoft, Palo Alto Networks and Unisys are named as Leaders in two quadrants each. Cato Networks, Check Point Software, Cisco, CrowdStrike, CyberArk, Forcepoint, Leidos, ManageEngine, Netskope, Okta, One Identity (OneLogin), Ping Identity, SailPoint, Saviynt, SentinelOne, Trellix, Trend Micro, Versa Networks and Zscaler are named as Leaders in one quadrant each. In addition, Leidos is named as a Rising Star — a company with a 'promising portfolio' and 'high future potential' by ISG's definition — in two quadrants. BeyondTrust, HPE (Aruba), Sophos and Wipro are named as Leaders in one quadrant each. In the area of customer experience, PwC is named the global ISG CX Star Performer for 2025 among cybersecurity service and solution providers. PwC earned the highest customer satisfaction scores in ISG's Voice of the Customer survey, part of the ISG Star of Excellence™ program, the premier quality recognition for the technology and business services industry. A customized version of the report is available from Unisys. The 2025 ISG Provider Lens® Cybersecurity — Services and Solutions report for the U.S. Public Sector is available to subscribers or for one-time purchase on this webpage. About ISG Provider Lens® Research The ISG Provider Lens® Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Canada, Mexico, Brazil, the U.K., France, Benelux, Germany, Switzerland, the Nordics, Australia and Singapore/Malaysia, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage. About ISG ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world's top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.
Business Wire
3 hours ago
- Business Wire
Dropzone AI Secures $37M Series B, Putting AI Security Analysts on the Front Lines of Cyber Battlefield
SEATTLE--(BUSINESS WIRE)--Dropzone AI, the leading provider of AI SOC analysts, has raised $37 million in Series B funding, led by Theory Ventures and joined by Madrona, Decibel Ventures, Pioneer Square Labs, and IQT. This infusion of funding validates Dropzone AI's unique solution as it leads the market for AI SOC agents, delivering measurable and transformative security outcomes for clients like UiPath, Zapier, Pipe, Assala Energy, and over 100 other enterprises. Their AI-native approach equips security teams with a superior defense - reducing security risks, operational costs, and analyst burnout - uniquely addressing the limitations of legacy cybersecurity solutions. 'Dropzone AI's ability to autonomously triage and investigate security alerts with human-level reasoning is a game-changer in a market that's overwhelmed by alert fatigue and attack frequency," said Vivek Ramaswami, Partner at Madrona Ventures. "At Madrona we look for founders who are passionate about advancing their sector and have the technical ability to do so; Edward exemplifies this pairing of vision and acumen. We're proud to support him and the Dropzone team in building what modern security teams need to stay ahead." According to the 2024 ISC2 Cybersecurity Workforce Study, 67% of respondents face staffing shortages, worsened by layoffs and budget cuts, making it more difficult to secure their organizations and driving interest in AI SOC solutions as leaders recognize the need for fundamental change. Recent Gartner® research1 predicts that, 'multiagent AI in threat detection and incident response will rise from 5% to 70% of AI implementations to primarily augment — not replace — staff.' Additionally, we were recently named a Sample Vendor for AI SOC Agents within the 2025 Gartner® Hype Cycle ™ for Security Operations2. Dropzone AI is at the forefront of this transformative shift in cybersecurity strategies and investments, set to fundamentally redefine cybersecurity operations. 'Dropzone AI SOC analyst's performance is exceptional, delivering detailed, high-fidelity alerts within minutes,' said Andrew Marsh, Director of Information Security at Indiana Farm Bureau Insurance. 'This transparent, rapid processing and accuracy significantly elevates threat response capabilities.' Dropzone AI autonomously investigates security alerts, replicating the techniques of elite analysts and allowing SOCs to achieve coverage and speed that was not previously possible. CBTS, a North American IT services provider, uses Dropzone AI to enhance the efficiency and quality of its managed detection and response service. By offloading 30–50% of alert volume, the platform has significantly reduced repetitive work, allowing the team to focus more on threat hunting, customer onboarding, and improving coverage. 'Today's funding fortifies our market lead,' said Edward Wu, Founder and CEO of Dropzone AI. 'We're driving a generational shift in cybersecurity from manpower-bound, alert-chasing SOC teams to SOC teams backed by an army of autonomous AI agents that get to focus on what truly matters. This change is not optional; it's essential. We exist to level the playing field for cyber defenders, and we can field these next-generation capabilities right now. We know who we're working for. We'll ensure they always outmatch the attackers.' The capital will be deployed across three strategic pillars. First, Dropzone AI will amplify its global footprint to meet surging demands by growing sales, marketing, and customer-success teams, so more security teams can better protect and enable their businesses without large increases in headcount or budget. Second, the company will fast-track the creation of additional specialized, autonomous AI agents for manual security tasks. Finally, it will deepen and extend its roster of ecosystem partnerships and technical integrations, ensuring its solutions can work with security teams of all sizes, tool stacks, and maturity to boost operational efficiency, sharpen threat detection, and drive stronger ROI. "As the AI SOC market has begun to mature, Dropzone has pulled ahead of the pack," said Tomasz Tunguz, General Partner at Theory. "Their AI SOC analysts have been validated by some of the world's largest enterprises and MSSPs, and are in production across dozens of businesses – along with recognition from analyst firms like Gartner and Forrester. Dropzone's sales have taken off as they've established their position as a trusted category leader; we were excited to double down in the Series B to further accelerate their efforts and shape what's next in AI-native security platforms." To learn more about Dropzone AI or to book a demo, please visit: About Dropzone AI Dropzone AI weaponizes LLMs for cyber defenders, equipping them with armies of AI agents so that they can overmatch attackers. With Dropzone autonomously handling routine Tier 1 alert triage, organizations can spend less time on reactive security and more time on proactive security. The Dropzone AI SOC Analyst replicates the techniques of elite analysts and is trusted by more than 100 organizations, including Mysten Labs, Pipe, UiPath, and Zapier. Learn more by visiting ______________________________ 1 Gartner, 'Emerging Tech: Techscape for Detection and Response Startups,' Bhatia, Esha, and Apeksha Kaushik. , March 19, 2025. GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved. 2 Gartner, 'Hype Cycle for Security Operations, 2025,' Nunez, Jonathan, and Darren Livingstone, June 23, 2025. Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. Expand
